This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.
Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
Related Post
Employer-Sponsored Coverage Rates for People Ages 0-64 by Federal Poverty Level (FPL)
...
Copay Adjustment Programs: What Are They and What Do They Mean for Consumers?
Drug makers sometimes offer copay coupons to lower consumers’ out-of-pocket costs for their brand-name prescriptions, though how private health plans ...
Dependent Coverage for Young Adults in Employer-Sponsored Health Plans
Young adults, particularly those ages 18-25, are more likely to be covered as dependents than adults overall (72% vs. 32%). ...
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs
More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical ...
Explaining Litigation Challenging the ACA’s Preventive Services Requirements: Braidwood Management Inc. v. Becerra
This brief explains the preventive services coverage requirements, the basis of the Braidwood Management Inc. v. Becerra lawsuit, next steps ...
Employer-Sponsored Health Insurance 101
This Health Policy 101 chapter explores employer-sponsored health insurance (ESI), the primary health coverage source for non-elderly residents in the ...
2025 California Health Benefits Survey
The survey provides an in-depth look at trends in employer-sponsored coverage in California, including premiums, cost sharing, offer rates, and ...
Deductibles in ACA Marketplace Plans, 2014-2025
This analysis documents average deductibles for Affordable Care Act Marketplace plans available on Healthcare.gov in 2025 for all metal tiers, ...
Challenges with Effective Price Transparency Analyses
Promoting price transparency in health care is a policy approach with bi-partisan support in Congress and the public at large. ...
2024 Employer Health Benefits Chart Pack
This slideshow captures key data from the 2024 KFF Employer Health Benefits Survey survey, providing a detailed look at trends ...